Categories: BuildingDevelopmentPlatform
Location: China, Chongqing, Wuxi
Investors 1
Funding Rounds 1
Date | Series | Amount | Investors |
03.03.2025 | Series C | $100M | - |
Mentions in press and media 4
Date | Title | Description |
03.03.2025 | Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing | SHANGHAI, March 3, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This roun... |
02.01.2024 | Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval | SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), recently announced that it has successfully obtained Humanitarian U... |
07.09.2022 | Pulnovo Medical Limited's PADN Technology Included in 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of PH | SHANGHAI, Sept. 7, 2022 /PRNewswire/ -- A globally recognized OTM innovative platform Pulnovo Medical Limited's proprietary Pulmonary Artery Denervation (PADN) technology has been included in the 2022 ESC/ERS Guidelines for the Diagnosis an... |
- | Pulnovo Medical | “Pa Mother medical” |
Reviews 0